Share your insights

Help us by sharing what content you've recieved in your exams


Atopic dermatitis and eczema

Background knowledge 🧠

Definition

  • Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin condition.
  • Commonly associated with other atopic diseases, such as asthma and allergic rhinitis.
  • Characterised by intense pruritus and eczematous lesions.
  • Primarily affects flexural areasΒ in older children and adults.
  • In infants, the face and extensor surfaces are commonly involved.

Epidemiology

  • Affects 15-20% of children and 2-10% of adults in the UK.
  • Onset typically occurs before the age of 5 years.
  • Prevalence has increased in recent decades.
  • More common in urban areas and industrialised countries.
  • Often associated with a family history of atopic disease.

Aetiology and Pathophysiology

  • Complex interaction between genetic, immunological, and environmental factors.
  • Mutations in the filaggrin (FLG) gene can lead to skin barrier dysfunction.
  • Th2-skewed immune response contributes to inflammation.
  • Environmental triggers include allergens, irritants, and climate.
  • Emotional stress can exacerbate the condition.

Types

  • Infantile AD: Begins at 2-6 months, often on cheeks, scalp, and extensor surfaces.
  • Childhood AD: Affects flexural areas such as the elbows, knees, and neck.
  • Adult AD: Predominantly flexural but can affect hands and eyelids.
  • Discoid eczema: Circular, well-demarcated plaques, usually on limbs.
  • Eczema herpeticum: Severe form with viral infection (HSV), requiring urgent treatment.

Clinical Features 🌑️

Symptoms

  • Intense pruritus, often worse at night.
  • Dry, scaly skin.
  • Erythema (redness).
  • Lichenification (thickened skin) in chronic cases.
  • Exacerbations triggered by stress, allergens, and climate.

Signs

  • Erythematous, eczematous plaques, often excoriated.
  • Crusting and oozing in acute flares.
  • Lichenification in chronic stages, particularly in flexural areas.
  • Post-inflammatory hyperpigmentation or hypopigmentation.
  • Secondary infections (e.g., Staphylococcus aureus) common.

Investigations πŸ§ͺ

Tests

  • Diagnosis is primarily clinicalΒ based on history and examination.
  • Skin swabs: To rule out secondary bacterial infection.
  • Patch testing: To identify contact allergens in suspected allergic contact dermatitis.
  • Serum IgE: Often elevated but not diagnostic.
  • Skin biopsy: Rarely needed, may help in atypical cases.

Management πŸ₯Ό

Management

  • Emollients: Regular use to maintain skin hydration.
  • Topical corticosteroids: First-line treatment for flares.
  • Topical calcineurin inhibitors: Used in sensitive areas like the face.
  • Antihistamines: To reduce pruritus, especially at night.
  • Systemic treatments (e.g., ciclosporin, methotrexate): For severe, refractory cases.
  • Phototherapy: Narrowband UVB for moderate to severeΒ cases.
  • Patient education: Importance of adherence to treatment and trigger avoidance.

Complications

  • Secondary bacterial infection: Commonly due to Staphylococcus aureus.
  • Eczema herpeticum: Disseminated HSV infection, a medical emergency.
  • Psychosocial impact: Depression and anxiety are common.
  • Sleep disturbance: Due to intense pruritus.
  • Post-inflammatory pigment changes: Hyperpigmentation or hypopigmentation.

Prognosis

  • Many children outgrow the condition by adolescence.
  • Chronic relapsing course in those who do not outgrow it.
  • Quality of life may be significantly impacted, particularly in severe cases.
  • With appropriate management, long-term control is possible.

Key Points

  • AD is a chronic, relapsing inflammatory skin condition with significant morbidity.
  • Management focuses on skin hydration, reducing inflammation, and avoiding triggers.
  • Complications include infection and psychosocial impact.
  • Multidisciplinary approach may be needed for severe cases.
  • Early intervention and patient education are crucial for long-term control.

No comments yet πŸ˜‰

Leave a Reply

Child health